P-31-NMR STUDIES OF THE KINETICS OF BISALKYLATION BY ISOPHOSPHORAMIDE MUSTARD - COMPARISONS WITH PHOSPHORAMIDE MUSTARD

被引：37

作者：

BOAL, JH

WILLIAMSON, M

BOYD, VL

LUDEMAN, SM

EGAN, W

机构：

[1] CATHOLIC UNIV AMER,DEPT CHEM,WASHINGTON,DC 20064

[2] TRINITY COLL,DEPT CHEM,WASHINGTON,DC 20017

[3] US FDA,CTR BIOL EVALUAT & RES,BIOPHYS LAB,BETHESDA,MD 20892

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 1989年 / 32卷 / 08期

关键词：

D O I：

10.1021/jm00128a018

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

页码：1768 / 1773

页数：6

共 38 条

[21]

MARTI C, 1985, CANCER TREAT REP, V69, P115

[22] OPTIMIZATION OF EXPERIMENTAL PROCEDURES FOR FAST ATOM BOMBARDMENT MASS-SPECTROMETRY [J].

MARTIN, SA ;

COSTELLO, CE ;

BIEMANN, K .

ANALYTICAL CHEMISTRY, 1982, 54 (13) :2362-2368

[23] IFOSFAMIDE WITH MESNA UROPROTECTION AND ETOPOSIDE - AN EFFECTIVE REGIMEN IN THE TREATMENT OF RECURRENT SARCOMAS AND OTHER TUMORS OF CHILDREN AND YOUNG-ADULTS [J].

MISER, JS ;

KINSELLA, TJ ;

TRICHE, TJ ;

TSOKOS, M ;

JAROSINSKI, P ;

FORQUER, R ;

WESLEY, R ;

MAGRATH, I .

JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (08) :1191-1198

[24]

PANNETIER G, 1967, CHEM KINETICS, P186

[25]

PINKERTON CR, 1985, CANCER CHEMOTH PHARM, V15, P258

[26]

PRATT CB, 1986, P AM ASSOC CANC RES, V27, P179

[27]

PRATT CB, 1987, CANCER TREAT REP, V71, P131

[28]

ROSS SL, 1974, DIFF EQUAT+, P57

[29]

SEEBER S, 1984, TUMORDIAGN THER, V5, P39

[30]

Stec W.J., 1982, ORGANOPHOSPHORUS CHE, V13, P145

← 1 2 3 4 →